Insulin-sensitizing agents for infertility treatment in woman with polycystic ovary syndrome: a narrative review of current clinical practice
CONCLUSION: The future of medical treatment of PCOS women with infertility lies in a personalized pharmacological approach, which involves various compounds with different mechanisms of action that could modify ovarian function and endometrial receptivity, ultimately leading to better overall reproductive outcomes in these women.PMID:37792213 | DOI:10.1007/s42000-023-00494-y
Source: Hormones - Category: Endocrinology Authors: Radmila Spari ć Mladen Andji ć Aleksandar Raki ć Jelica Bjeki ć-Macut Sarantis Livadas Olivera Konti ć-Vučinić George Mastorakos Djuro Macut Source Type: research
More News: Child Development | Clinical Trials | Clomid | Endocrinology | Fortamet | Hormones | Infertility | Insulin | Metformin | Ovaries | Polycystic Ovary Syndrome | Reproduction Medicine | Women